• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Arthrosurface

Arthrosuface sold to Anika Therapeutics for $100m

January 14, 2020 By Sean Whooley

Primo Medical Group announced that it completed the $100 million sale of spin-off company Arthrosurface to Anika Therapeutics (NSDQ:ANIK). Under the agreement, Anika is set to acquire all outstanding shares of Arthrosurface in exchange for $100 million in total, starting with an upfront payment of approximately $60 million in cash from Anika’s existing balance sheet. The […]

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, Orthopedics Tagged With: Anika Therapeutics Inc., Arthrosurface, Primo Medical Group

FDA clears Arthrosurface’s Boss toe implant

September 6, 2019 By Sean Whooley

Arthrosurface said yesterday that it received FDA 510(k) clearance for its Boss toe fixation system, which the company believes will be commercially available at the end of the month. The Franklin, Mass.-based company said the Boss system is designed to improve stabilization in the first metatarsal with a distal bone void and to provide patients […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Regulatory/Compliance, Surgical Tagged With: Arthrosurface, FDA

Rethinking orthopedic implants with Arthrosurface CEO Steve Ek | DeviceTalks Podcast

June 24, 2019 By Sarah Faulkner

Arthrosurface president & CEO Steve Ek talked to reporter Sarah Faulkner about the company’s motion-preserving joint replacement technology. Want to see these interviews live? Join us at DeviceTalks.  Sarah: Steve’s office is not your typical corporate office. It’s filled with models of the human skeletal system and demos of the company’s implants. It’s a good […]

Filed Under: Device Talks Podcasts, Featured, Orthopedics Tagged With: Arthrosurface, DeviceTalks

Arthrosurface touts Ovo shoulder study

May 4, 2019 By Brad Perriello

Arthrosurface said last week that data from a study of its Ovo with inlay glenoid shoulder arthroplasty system showed strengths in pain relief, patient satisfaction and functional improvements in patients with glenohumeral arthritis. The Franklin, Mass.-based company’s OvoMotion is a stemless total shoulder system is designed to minimize bone removal specifically for patients with painful […]

Filed Under: Clinical Trials, Implants Tagged With: Arthrosurface

Arthrosurface nabs 510(k) clearance for patellofemoral WaveKahuna arthroplasty system

July 5, 2018 By Sarah Faulkner

Arthrosurface said last month that it won 510(k) clearance from the FDA for its patellofemoral WaveKahuna arthroplasty system. The Franklin, Mass.-based company’s PF WaveKahuna device is designed to restore the articular surface geometry of the patella and femoral trochlea. The system tackles the challenging PF tracking and stability conditions and gives increased coverage of the […]

Filed Under: 510(k), Food & Drug Administration (FDA), Orthopedics, Regulatory/Compliance Tagged With: Arthrosurface

Arthrosurface wins FDA nod for OVOMotion shoulder arthroplasty system

April 19, 2018 By Fink Densford

Arthrosurface said yesterday it won FDA 510(k) clearance for its OVOMotion shoulder arthroplasty system. The Franklin, Mass.-based company said the newly cleared stemless total shoulder system is designed to minimize bone removal specifically for patients with painful or severely disabled shoulder joints from arthritis, traumatic events or avascular necrosis. “This truly is a revolutionary stemless […]

Filed Under: 510(k), Food & Drug Administration (FDA), Orthopedics, Regulatory/Compliance Tagged With: Arthrosurface

Arthrosurface acquires allograft tech from Wasas

October 30, 2017 By Brad Perriello

Arthrosurface said today that it paid an unspecified amount to acquire an acellular dermal stabilization device technology from Wasas LLC. Derived from human tissue, acellular dermis is made using a process that removes cells but retains portions of the extracellular matrix to create dermal allografts. The deal includes the patent rights for the technology, which Franklin, Mass.-based Arthrosurface […]

Filed Under: Mergers & Acquisitions, Orthopedics, Wall Street Beat Tagged With: Arthrosurface, wasas

Arthrosurface touts FDA win for ToeMotion Total Toe tech

March 28, 2014 By Arezu Sarvestani Leave a Comment

Arthrosurface touts FDA win for ToeMotion Total Toe tech

Massachusetts-based joint devices maker Arthrosurface landed FDA clearance for its ToeMotion Total Toe fixation system, the company announced this month.

Launched during the AAOS conference in New Orleans, the ToeMotion Total Toe system aims to fix the joint and preserve bone without jeopardizing the stability of the toe.

 

Filed Under: Implants, News Well, Orthopedics Tagged With: Arthrosurface

Arthrosurface passes the 20,000-patient mark

May 25, 2010 By MassDevice staff Leave a Comment

Arthrosurface logo

Arthrosurface’s joint preservation devices have made their way into the joints of over 20,000 patients.

The Franklin, Mass.-based company’s inlay joint resurfacing systems have treated over 20,000 patients, with 98% of the screw-in devices still in place.

The company said its products delay the need for joint replacements while preserving the active lifestyles of its Baby-Boomer customers.

Filed Under: Business/Financial News, Implants, News Well, Orthopedics Tagged With: Arthrosurface

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy